Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
mLSG15 + KW-0761 vs mLSG15 in untreated CCR4-positive adult T-cell leukemia-lymphoma
jRCT2080221172Phase 2
- Sponsor
- Kyowa Kirin
- Start
- Jul 2010
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of mogamulizumab in adult T-cell leukemia-lymphoma (ATLL) (2 arms), sponsored by Kyowa Kirin.
02
Drugs
mogamulizumab
03
Conditions
adult T-cell leukemia-lymphoma (ATLL)
Beyond the preview
Go deeper on jRCT2080221172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221172.